TelehealthReviewed.com today published a new industry trend report examining the rising consumer interest in compounded tirzepatide telehealth programs throughout 2026. The report analyzes how provider-guided platforms structure these programs, what factors consumers most commonly evaluate, and how the dual-action mechanism of tirzepatide is positioned within the broader online weight management landscape.